Keywords: humira, gets, eu, ok, severe, crohn, health

Humira gets EU OK for severe Crohn's

Article | 18 June 2007

US health care major Abbott Laboratories says that the European Commission has granted its anti-tumor necrosis factor therapy Humira (adalimumab) ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Abbott

Abbott Laboratories

Go to company listing

Related Drugs

adalimumab

Humira

Go to drug listing